2003
DOI: 10.1016/s0142-9612(02)00374-5
|View full text |Cite
|
Sign up to set email alerts
|

Structural and human cellular assessment of a novel microsphere-based tissue engineered scaffold for bone repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

13
159
2

Year Published

2005
2005
2013
2013

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 207 publications
(174 citation statements)
references
References 25 publications
13
159
2
Order By: Relevance
“…[31] In particular, a sintered microsphere matrix from PLAGA has attracted significant interest as a load-bearing scaffold for orthopaedic tissue engineering. [23, 34] However, for large porous structures the use of a bioreactor might be essential for complete cell infiltration, because the preformed structures present nutrient and oxygen diffusion limitations. [35] A 12-week of blend degradation in vivo resulted in a porosity of 82-87% which is structurally similar to cancellous bone.…”
Section: Discussionmentioning
confidence: 99%
“…[31] In particular, a sintered microsphere matrix from PLAGA has attracted significant interest as a load-bearing scaffold for orthopaedic tissue engineering. [23, 34] However, for large porous structures the use of a bioreactor might be essential for complete cell infiltration, because the preformed structures present nutrient and oxygen diffusion limitations. [35] A 12-week of blend degradation in vivo resulted in a porosity of 82-87% which is structurally similar to cancellous bone.…”
Section: Discussionmentioning
confidence: 99%
“…In PLLA scaffolds, vascular smooth muscle cells preferentially bind to one range of pore sizes (63 -150 µm) while fibroblasts bind to a wider range (38 -150 µm) [12,13]. A number of cell types exhibit preferences to binding in scaffolds with pore sizes considerably larger than the characteristic cell size, often utilizing a characteristic bridging mechanism where adjacent cells act as support structures to assist bridging large pores; examples include fibrovascular tissue ingrowth into PLLA scaffolds, osteoblast adhesion to polylactide-co-glycolide (PLAGA) scaffolds, and rat marrow cells binding to PEOT/PBT scaffolds [7,14,15]. Additionally, the mean pore size of scaffolds has also been shown to significantly influence cell morphology and phenotypic expression [16][17][18].…”
Section: Introductionmentioning
confidence: 99%
“…Formulations containing drug-loaded nanoparticles often allow for controlled and slow release. Recently reports were published on using PLGA microspheres as building blocks for the preparation of polymeric scaffolds with controlled porosity for tissue engineering [9,10].…”
Section: Introductionmentioning
confidence: 99%